SITAGLIPTIN (SITAGLIPTIN PHOSPHATE) — FDA Approval ANDA216919 (MANKIND PHARMA LTD)
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE) — FDA Approval ANDA216919 (MANKIND PHARMA LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SITAGLIPTIN; Active ingredients: SITAGLIPTIN PHOSPHATE; Application number: ANDA216919.
| Brand name | SITAGLIPTIN |
|---|---|
| Active ingredients | SITAGLIPTIN PHOSPHATE |
| Application number | ANDA216919 |
| Sponsor | MANKIND PHARMA LTD |
| Dosage form | TABLET |
| Route | FILM COATED |
| Marketing status | None (Tentative Approval) |
| Products in application | 3 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →